|
Widely recognized expertise in ocular pathology in humans and animals with experience working with companies to provide a full range of eye pathology services from consultation on study design to peer review.
How can we help you?
We can provide expertise in...
- Choice of Animal Models
- Peer review of studies
- Fixation for ocular tissues
- Using the best technology
- Paraffin
- Plastic sectioning
- EM
- Immunohistochemistry
We have expertise in...
- The pathology of spontaneous eye diseases in animals and humans
- Working with companies to solve pathology issues
- Ocular implants
- Animal models of eye disease
- CNV
- Glaucoma
- Inflammation
- Tumors
- Corneal diseases
- Diabetic retinopathy
- Cataract
Richard R. Dubielzig, D.V.M., Dipl. ACVP: Dr. Dubielzig is the Director of C.O.P.L.O.W., an ocular pathology service providing diagnostic services to Veterinary Ophthalmologists around the world. The service logs more than 100 cases per month and is used by more than 100 Ophthalmologists. Dr. Dubielzig has published on comparative ocular neoplasia, uveitis, glaucoma, and heritable eye diseases. He has worked on safety evaluation studies and efficacy studies with numerous companies.
Daniel M. Albert, M.D.: Dr. Albert is director of the Wisconsin Ocular Pathology Laboratory and former Chairman of the Dept. of Ophthalmology and Visual Sciences. He is an author on more than 400 articles in ophthalmic pathology and numerous books and book chapters on the subject. He is best known for his pioneering work in retinoblastoma. Dr. Albert has worked on safety evaluation studies and efficacy studies with numerous companies.
T. Michael Nork, M.D.: Dr. Nork is an Ophthalmologist with a special interest in Vitreoretinal surgery and pathology. His research in pathology is focused on photoreceptor morphology in health and disease. He has published on retinoblastoma, senile retinal degeneration, and glaucoma.
Laser induced choroidal neovascularization in a primate model
 Photoreceptor toxicity in a feline safety evaluation
Inflammatory response to protein substance delivered within the vitreous
Cytokeratin + endothelial cells in transgenic
mouse model for posterior polymorphous
corneal dystrophy
Back
Go to top
| 
